New antitrust proposals from the Department of Justice and the Federal Trade Commission would allow antitrust regulators greater authority to scrutinize healthcare mergers and acquisitions, if finalized. On today’s episode of Gist Healthcare Daily, we hear the second part of JC’s conversation with Stuart Vogelsmeier, EVP and Chair of the Healthcare and Business practices at St. Louis-based law firm Lashly & Baer, about how these proposed guidelines could impact healthcare transactions. 

You can listen to the first part of our conversation here. 

Hosted on Acast. See acast.com/privacy for more information.